CHRONIC PAIN
CHRONIC PAIN
ELECTRIC CELL SIGNALING- A DRUG FREE OPTION FOR LONG-TERM INTRACTABLE PAIN
PAIN DOES NOT HAVE TO BE
PART OF GETTING OLDER!
Areas most commonly treated:
BACK
NECK
SHOULDER
KNEE
HIP
HANDS
FEET
ELECTRIC CELL SIGNALING TREATMENTS:
Take approximately 20 minutes
Administered twice per week
Most are authorized for 20 treatments per area
Work best when combined with exercise, anti-inflammatory diet, and other therapies to address the root cause
Benefits:
Safe, effective, and non-invasive
No addictive pain medications
Covered by most insurances
Minimal potential for side effects
Extremely high patient outcomes and satisfaction
You are one step away from answers.
GET STARTED WITH BLUE UMBRELLA TODAY.
EDUCATION IS EMPOWERMENT
Allergies...Who Needs Them Anyway?
We love you, but it's time to talk. Your outdoors contain an unreal amount of beauty, from the Smoky Mountains to the Mississippi River, but if you want us to enjoy them, these seasonal allergies have... ...more
Allergies
June 25, 2023•2 min read
White Paper: Sanexas neoGEN-Series Device and Electric Cell Signaling Treatment
Peripheral neuropathy is a condition often associated with diabetes (about 60% of patients who suffer from diabetes will develop peripheral neuropathy) but it can also be caused by chemotherapy treatm... ...more
Treatment
June 25, 2023•7 min read
Fast Effective Neuropathy Relief
Peripheral neuropathy is a condition often associated with diabetes (about 60% of patients who suffer from diabetes will develop peripheral neuropathy) but it can also be caused by chemotherapy treatm... ...more
White Pape
June 25, 2023•4 min read
Customer Testimonials
Disclaimer: None of the statements on this page are intended to make any claims about HTT, but instead describe many of the basic functions of native human tissue. Per FDA Guidance, it is not necessary for the HCT/P in the recipient to perform all of the basic functions it performed in the donor in order to meet the definition of homologous use. Human Tissue Therapy, as we use that term on this website, are minimally manipulated cells and tissues intended for homologous use only. None of the mentioned statements have been evaluated by the FDA. As defined in 21 CFR 1271.3(c), homologous use means the repair, reconstruction, replacement, or supplementation of a recipient’s cells or tissues with an HTT/P that performs the same basic function or functions in the recipient as in the donor. Human Tissue Therapies are not intended to diagnose, treat, cure or prevent any disease including COVID-19.
